Lyroxen CR 82.5 mg (Tablet (Controlled Release))
Unit Price: ৳ 25.00 (2 x 10: ৳ 500.00)
Strip Price: ৳ 250.00
Medicine Details
Category | Details |
---|---|
Generic | Pregabalin |
Company | Everest pharmaceuticals ltd |
Also available as |
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Pharmacology
Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABA receptors but binds with high affinity to the alpha2-delta site in central nervous system tissues, which may be involved in its anti-nociceptive and antiseizure effects.
Dosage
- DPN: Maximum recommended dose of Pregabalin is 100 mg three times a day for patients with creatinine clearance of at least 60 ml/min
- PHN: Recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day
- Fibromyalgia: Recommended dose of Pregabalin is 300 to 450 mg/day
- Spinal cord injury: Recommended dose range of Pregabalin is 150 to 600 mg/day
- Special Instructions: Pregabalin CR tablet should be administered after an evening meal and swallowed whole
Administration
- Route: Oral
- Instructions: Can be taken with or without food. Pregabalin CR tablet should be administered after an evening meal and swallowed whole.
Interaction
- Drug: Unlikely to be involved in significant pharmacokinetic drug interactions
Contraindications
Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components
Side Effects
- Dizziness
- Somnolence
- Dry mouth
- Edema
- Blurred vision
- Weight gain
- Thinking abnormal
- Increased weight (in pediatric patients)
- Increased appetite (in pediatric patients)
Pregnancy & Lactation
- Pregnancy: No adequate and well-controlled studies; potential risk to fetus
- Lactation: Small amounts detected in the milk of lactating women; breastfeeding not recommended
Precautions & Warnings
- Angioedema can occur and may be associated with life threatening respiratory compromise requiring emergency treatment
- Discontinue immediately in case of hypersensitivity reactions
- Increase in risk of suicidal thoughts or behavior
- Respiratory depression may occur when used with concomitant CNS depressants
- May cause dizziness and somnolence, impairing ability to drive or operate machinery
- Increased seizure frequency or other adverse reactions if rapidly discontinued
- May cause peripheral edema
- Caution should be exercised when coadministering with thiazolidinedione antidiabetic agents
Use in Special Populations
- Children and Adolescents: Safety and effectiveness not established for various uses
Overdose Effects
Symptoms include reduced consciousness, depression/anxiety, confusional state, and seizures; no specific antidote
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
Keep in a cool & dry place (below 30°C), protected from light & moisture; keep out of the reach of children
Chemical Structure
- Molecular Formula: C8H17NO2
Related Brands
- Pregaben CR 165 mg (Tablet (Controlled Release)) - incepta-pharmaceuticals-ltd
- Pregaben CR 82.5 mg (Tablet (Controlled Release)) - incepta-pharmaceuticals-ltd
- Nerfid 150 mg (Capsule) - the-white-horse-pharmaceuticals-ltd
- Nerfid 25 mg (Capsule) - the-white-horse-pharmaceuticals-ltd
- Pregaba ER 330 mg (Tablet (Extended Release)) - opsonin-pharma-ltd